Difference between revisions of "Improve Data Sharing, Analysis, and Monitoring"
| Line 12: | Line 12: | ||
= Understanding the Problem - Data Collection and Analysis = | = Understanding the Problem - Data Collection and Analysis = | ||
| − | A key goal of any effort to address the current | + | A key goal of any effort to address the current epidemic is to use multi-sector data to inform response strategies and decision making. Most communities need to break down data silos so that various public, private, and community partners can engage effectively. This process also increases understanding and fosters collaboration. All participants need to understand what is happening in their community in order to have agreement about what strategies would be most effective. |
| | ||
| Line 18: | Line 18: | ||
== Questions to Consider == | == Questions to Consider == | ||
| − | Substance use disorder and drug misuse are complex problems requiring a | + | Substance use disorder and drug misuse are complex problems requiring a complete set of solutions. Most communities will start their exploration of data by looking at the most severe harms - including fatal and non-fatal overdoses. Knowing the numbers is important to understand the scope of the problem, but to guide response more data is required. For example, where are the overdoses occurring? What are the demographics? What type of substance, or combination, is involved? |
This starting point typically leads to other questions that require additional data in order to identify gaps in services and implementation of strategies to fill such gaps. Some examples include: | This starting point typically leads to other questions that require additional data in order to identify gaps in services and implementation of strategies to fill such gaps. Some examples include: | ||
| Line 24: | Line 24: | ||
'''For non-fatal overdoses, how many go to a hospital or community health center?''' | '''For non-fatal overdoses, how many go to a hospital or community health center?''' | ||
| − | '''How many are revived with | + | '''How many are revived with Naloxone? By first responders? Others?''' |
| − | '''Are there clusters of overdoses | + | '''Are there clusters of overdoses occurring in specific areas and neighborhoods?''' |
'''Are overdose prevention services being offered in areas with high overdose rates?''' | '''Are overdose prevention services being offered in areas with high overdose rates?''' | ||
| Line 32: | Line 32: | ||
'''What drugs are residents using? What are the trends?''' | '''What drugs are residents using? What are the trends?''' | ||
| − | '''What are the local | + | '''What are the local opioid prescribing practices?''' |
'''Are people experiencing overdose being connected to services? How is this being done, and by whom?''' | '''Are people experiencing overdose being connected to services? How is this being done, and by whom?''' | ||
| Line 50: | Line 50: | ||
'''Local and State Health Departments (number of overdoses, locations, demographics)''' | '''Local and State Health Departments (number of overdoses, locations, demographics)''' | ||
| − | '''Fire/EMS Services (portion of overdoses, connection to services, | + | '''Fire/EMS Services (portion of overdoses, connection to services, naloxone in some cases)''' |
'''Police and Public Safety Departments (overdoses, drug seizures, drug-related crime, diversion and MAT in correctional facilities)''' | '''Police and Public Safety Departments (overdoses, drug seizures, drug-related crime, diversion and MAT in correctional facilities)''' | ||
| Line 58: | Line 58: | ||
'''911 Calls (calls related to suspected overdose)''' | '''911 Calls (calls related to suspected overdose)''' | ||
| − | '''Local Hospitals and Community Health Organizations ( | + | '''Local Hospitals and Community Health Organizations (number of non-fatal overdoses, connection to services, naloxone)''' |
| − | '''Local Harm Reduction service providers. ( | + | '''Local Harm Reduction service providers. (naloxone and needle distribution, connection to services)''' |
'''Treatment Providers (treatment capacity and availability, wait times, MAT providers)''' | '''Treatment Providers (treatment capacity and availability, wait times, MAT providers)''' | ||
| − | '''Pharmacy records on | + | '''Pharmacy records on Naloxone distribution. (Indication of awareness and/or increased use)''' |
'''Prescription Drug Monitoring Program (PDMP) data (identify high risk prescribers)''' | '''Prescription Drug Monitoring Program (PDMP) data (identify high risk prescribers)''' | ||
Revision as of 02:03, 27 October 2020
Return to Opioid Top-Level Strategy Map Data collection and analysis represents a critical component to community efforts to improve response to drug misuse and substance use disorder. Data collection across local government and community partners builds knowledge and informs decision making. Comprehensive, accurate data enables more effective interventions and strategies. Making certain data publicly available helps informs residents about the scope of the problem and can encourage engagement. The continued collection and monitoring of critical data provides needed information regarding the effectiveness of a given set of strategies undertaken in each community.
Contents
Understanding the Problem - Data Collection and Analysis
A key goal of any effort to address the current epidemic is to use multi-sector data to inform response strategies and decision making. Most communities need to break down data silos so that various public, private, and community partners can engage effectively. This process also increases understanding and fosters collaboration. All participants need to understand what is happening in their community in order to have agreement about what strategies would be most effective.
Questions to Consider
Substance use disorder and drug misuse are complex problems requiring a complete set of solutions. Most communities will start their exploration of data by looking at the most severe harms - including fatal and non-fatal overdoses. Knowing the numbers is important to understand the scope of the problem, but to guide response more data is required. For example, where are the overdoses occurring? What are the demographics? What type of substance, or combination, is involved?
This starting point typically leads to other questions that require additional data in order to identify gaps in services and implementation of strategies to fill such gaps. Some examples include:
For non-fatal overdoses, how many go to a hospital or community health center?
How many are revived with Naloxone? By first responders? Others?
Are there clusters of overdoses occurring in specific areas and neighborhoods?
Are overdose prevention services being offered in areas with high overdose rates?
What drugs are residents using? What are the trends?
What are the local opioid prescribing practices?
Are people experiencing overdose being connected to services? How is this being done, and by whom?
Are area treatment and other support services at capacity? Are there wait times to get in?
How many who need MAT are receiving it? Does this include the criminal justice system?
Are recovery support services - including housing, job training, coaching, and education - available and do they meet the needs of the community?
Potential Data Sources
The next step is to determine who has the needed data, and therefore who needs to participate in this process. To answer the necessary questions and inform decision making there are many possible data sources. Common sources and the type of data they can typically provide include:
Local and State Health Departments (number of overdoses, locations, demographics)
Fire/EMS Services (portion of overdoses, connection to services, naloxone in some cases)
Police and Public Safety Departments (overdoses, drug seizures, drug-related crime, diversion and MAT in correctional facilities)
Medical Examiner/Corners Reports (cause of death from overdose, type of substance(s) involved)
911 Calls (calls related to suspected overdose)
Local Hospitals and Community Health Organizations (number of non-fatal overdoses, connection to services, naloxone)
Local Harm Reduction service providers. (naloxone and needle distribution, connection to services)
Treatment Providers (treatment capacity and availability, wait times, MAT providers)
Pharmacy records on Naloxone distribution. (Indication of awareness and/or increased use)
Prescription Drug Monitoring Program (PDMP) data (identify high risk prescribers)
Community surveys related to drug use (trends in drug use, types of drugs, community perception of the problem)
Recovery Support Services (amount and adequacy of peers, housing, job training, tracking data on clients staying in recovery)
Building and Sharing Data
Data Sharing Agreements
Reporting Data
Public Reporting
Making Data Informed Decisions
Tracking Progress through Data Collection
Additional Resources
PAGE MANAGER: [insert name here] SUBJECT MATTER EXPERT: [fill out table below]
| Reviewer | Date | Comments |
Sources
</div>
